Potassium cyanate as an inhibitor of the sickling of erythrocytes in vitro.
about
Anti-sickling effect of dietary thiocyanate in prophylactic control of sickle cell anemiaThe effects of cyanate in vitro on red blood cell metabolism and function in sickle cell anemiaNoncovalent modification of deoxyhemoglobin S solubility and erythrocyte sickling.Cyanide, peroxide and nitric oxide formation in solutions of hydroxyurea causes cellular toxicity and may contribute to its therapeutic potency.Role of the alpha-amino group of protein in ubiquitin-mediated protein breakdown.Management of sickle-cell disease.Effects of cyanate and 2,3-diphosphoglycerate on sickling. Relationship to oxygenationEffect of increased blood oxygen affinity on work performance of rats.Life span of carbamylated red cells in sickle cell anemia.Methyl isocyanate eight-day vapor inhalation study with Fischer 344 rats.Biological effects of short-term, high-concentration exposure to methyl isocyanate. I. Study objectives and inhalation exposure design.The effect of aspirin on sickling and oxygen affinity of erythrocytes.Inhibition of erythrocyte sickling by cystamine, a thiol reagent.Alternative aspirins as antisickling agents: acetyl-3,5-dibromosalicylic acid.Structure of sickled erythrocytes and of sickle-cell hemoglobin fibers.Structure of fibers of sickle cell hemoglobin.Acetylation of sickle cell hemoglobin by aspirinConcerted formation of the gel of hemoglobin S.Sites of acetylation of sickle cell hemoglobin by aspirin.Effect of alkylureas on the polymerization of hemoglobin S.Management of sickle cell disorders.Nonenzymatic glycosylation of peripheral nerve protein in diabetes mellitus.Hematologic and clinical responses in patients with sickle cell anemia after chronic extracorporeal red cell carbamylation.Recombinant human sickle hemoglobin expressed in yeast.Antisickling activity of amino acid benzyl esters.Studies of pyruvate-water isotope exchange catalysed by erythrocytes and proteins.Effects of glyceraldehyde on the structural and functional properties of sickle erythrocytesChemical modifications that inhibit gelation of sickle hemoglobinIncreased survival of sickle-cell erythrocytes after treatment in vitro with sodium cyanate.Reversible transformation by urea of contact-inhibited fibroblasts.Erythrocytic mechanism of sickle cell resistance to malaria.Inhibition of erythrocyte sickling in vitro by DL-glyceraldehyde.A surprising journey in translational medicine.Nuclear magnetic resonance studies of hemoglobin: functional state correlations and isotopic enrichment strategies.Experience with isoxsuprine in the treatment of sickle cell crisis: a proposed mechanism of action.Sickle cell hemoglobin: molecular basis of sickling phenomenon theory and therapy.Review of the development of cyanate as a drug in the treatment of sickle cell anemia.Cyanate and hemoglobin-S: effect of carbamylation of the alpha and beta chain alpha-amino groups on O2 affinity.The sickling process in relation to clinical manifestations.The effect of hemoglobin carbamylation on the survival of human sickle cell erythrocytes in rats.
P2860
Q24649178-B5112FE3-8CF2-4DE8-855F-80572F06AA9AQ28364405-0E180F84-C7F5-4516-BAF4-A2FF883BB3BEQ30408104-7B804382-7FC3-4C24-B59F-682C794977A1Q30489589-02BBE2CC-524C-4374-B6F7-CF4C497D40A5Q34245587-089CE00B-081D-4A2A-AE6B-16B30CC5EFFCQ34302955-3D14F263-17DC-4B32-B212-332EA36E1986Q34511489-A86BE973-AB48-4414-83FE-7DF9BF362702Q34512786-EC3D588C-6270-4FFF-9296-2E8FCF9AE700Q34515826-CE13EB91-A6CA-4C5A-B08C-A59E674BDA62Q34661041-5135AAFF-C1B6-4CE2-A64A-C59C9267E97CQ34661195-1B31FAE3-31A6-488B-BC5E-C109C571C521Q34750488-33B92167-393E-4D93-89FC-84585523184BQ35025382-E008B197-9621-4A88-AB52-B9F1C55FEDB7Q35051404-AACE0E40-0778-4675-912B-FB09F7C3DA25Q35098122-A7BBFBB3-209A-48AC-922B-FD29AF9F0945Q35101022-E4E3FBA6-BA9E-4462-A70A-E6BA65A2575DQ35102807-BB94528B-8D12-4610-9E40-5ADFEF3CB601Q35104180-52A333DC-E6B8-4685-A02D-58ADA12E2FB6Q35118739-999B2FF7-E85E-46BE-98D9-5B6989A2D2B7Q35118950-3FF369E8-A312-400E-81CD-5E14C5124C03Q35145750-72EC5129-7B09-4703-BD9D-A546DDA3483FQ35469486-C85BA3DC-8714-49FD-A64E-5C08710335D1Q35904145-2263CC31-A7FB-4F8E-90BF-5A45572681F1Q36081432-D9FAD354-742B-4932-B195-4A5659BA2F35Q36350850-64A797D2-2D53-4B72-A13E-0655AFD47591Q36660389-58A59ECD-D89C-41E4-8308-77D3A999A607Q37049430-46D41788-A09E-4249-8182-A9EAFA25CAE5Q37440693-1FC0A33D-6C8A-4326-ACE6-696BE25084AEQ37491667-0F4B3AA9-EEBE-4928-AE87-D75298C2088DQ37503434-D1D121FC-15BC-43CC-BE77-B3B1009EA81AQ37584713-D07012D7-5B7A-486A-95AC-2CFC192B18B3Q37599281-B2647F21-C5C3-44BE-A815-C707143C4C50Q38562660-2C07158B-1627-4C95-B457-B6B44B79D089Q39082262-DAB6BDE4-21CC-4D20-90DF-E2E33BE326E3Q39568099-EC51B4D4-B5E3-42F0-AA9E-EC83F5208BDEQ39939407-AAC1D8BF-37C0-472E-B845-F50BC2343F79Q39949567-12E61B71-91F4-4133-B8F0-90C054589665Q40326119-836A2793-C4A5-429A-9DC7-256A73552B9EQ40907067-7A30B7E8-2972-4471-B880-C35174A1B222Q41237677-758254ED-DB73-44A2-9141-B0BAEA5E9B3B
P2860
Potassium cyanate as an inhibitor of the sickling of erythrocytes in vitro.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 1971
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Potassium cyanate as an inhibitor of the sickling of erythrocytes in vitro.
@en
Potassium cyanate as an inhibitor of the sickling of erythrocytes in vitro.
@nl
type
label
Potassium cyanate as an inhibitor of the sickling of erythrocytes in vitro.
@en
Potassium cyanate as an inhibitor of the sickling of erythrocytes in vitro.
@nl
prefLabel
Potassium cyanate as an inhibitor of the sickling of erythrocytes in vitro.
@en
Potassium cyanate as an inhibitor of the sickling of erythrocytes in vitro.
@nl
P2860
P356
P1476
Potassium cyanate as an inhibitor of the sickling of erythrocytes in vitro.
@en
P2093
P2860
P304
P356
10.1073/PNAS.68.6.1180
P407
P577
1971-06-01T00:00:00Z